NOBILIS PROTECTOTYPE Trademark

Trademark Overview


On Wednesday, May 22, 2024, a trademark application was filed for NOBILIS PROTECTOTYPE with the United States Patent and Trademark Office. The USPTO has given the NOBILIS PROTECTOTYPE trademark a serial number of 98563706. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, December 6, 2024. This trademark is owned by Intervet Inc.. The NOBILIS PROTECTOTYPE trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary vaccines

General Information


Serial Number98563706
Word MarkNOBILIS PROTECTOTYPE
Filing DateWednesday, May 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, December 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVeterinary vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntervet Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRahway, NJ 07065

Trademark Events


Event DateEvent Description
Wednesday, May 22, 2024NEW APPLICATION ENTERED
Wednesday, November 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 6, 2024ASSIGNED TO EXAMINER
Friday, December 6, 2024NON-FINAL ACTION WRITTEN
Friday, December 6, 2024NON-FINAL ACTION E-MAILED